Correlation Between Viridian Therapeutics and Creo Medical

Can any of the company-specific risk be diversified away by investing in both Viridian Therapeutics and Creo Medical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Viridian Therapeutics and Creo Medical into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Viridian Therapeutics and Creo Medical Group, you can compare the effects of market volatilities on Viridian Therapeutics and Creo Medical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Viridian Therapeutics with a short position of Creo Medical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Viridian Therapeutics and Creo Medical.

Diversification Opportunities for Viridian Therapeutics and Creo Medical

0.58

Correlation Coefficient

Viridian Therapeutics  Creo Medical

Very weak diversification

The 3 months correlation between Viridian and Creo is 0.58. Overlapping area represents the amount of risk that can be diversified away by holding Viridian Therapeutics and Creo Medical Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Creo Medical Group and Viridian Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Viridian Therapeutics are associated (or correlated) with Creo Medical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Creo Medical Group has no effect on the direction of Viridian Therapeutics i.e., Viridian Therapeutics and Creo Medical go up and down completely randomly.

Pair Corralation between Viridian Therapeutics and Creo Medical

Assuming the 90 days trading horizon Viridian Therapeutics is expected to under-perform the Creo Medical. In addition to that, Viridian Therapeutics is 1.43 times more volatile than Creo Medical Group. It trades about -0.02 of its total potential returns per unit of risk. Creo Medical Group is currently generating about 0.03 per unit of volatility. If you would invest  1,875  in Creo Medical Group on October 6, 2024 and sell it today you would earn a total of  25.00  from holding Creo Medical Group or generate 1.33% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	97.62%
Values	Daily Returns

Viridian Therapeutics  vs.  Creo Medical Group

Viridian Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Viridian Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unsteady performance, the Stock's basic indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.

Creo Medical Group

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Creo Medical Group has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest uncertain performance, the Stock's basic indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.

Pair Trading with Viridian Therapeutics and Creo Medical

The main advantage of trading using opposite Viridian Therapeutics and Creo Medical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Viridian Therapeutics position performs unexpectedly, Creo Medical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Creo Medical will offset losses from the drop in Creo Medical's long position.

The idea behind Viridian Therapeutics and Creo Medical Group pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.